Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post Here’s What Would Happen if MicroStrategy’s Bitcoin (BTC) Holdings Fell Below NAV June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts CHARBONE Hydrogen Announces $2M Convertible Debentures Replacement September 19, 2025 15 Canadian Crypto ETFs in 2025 September 19, 2025 Silver Hammer Closes CDN$1,809,000 Fully Subscribed Non-Brokered Private Placement of Units September 19, 2025
Silver Hammer Closes CDN$1,809,000 Fully Subscribed Non-Brokered Private Placement of Units September 19, 2025